This study showed that, despite, functional and structural conservation, Plasmodium aaRSs have key differences from the human homologues.
New genetic control methods for mosquitoes may reduce vector species without direct effects on other species or the physical environment common with insecticides or drainage.
A large proportion of FDC formulations available in India has never been approved by CDSCO, hence raising the doubts about their safety and efficacy.
Avian malaria is a mosquito-borne disease that affects multiple avian species and is caused by protozoans of the genus Plasmodium.
Malaria remains a major global threat to human health and economic development.
The LAMBA has higher validity than the sWHO and may therefore be preferable in resource‐limited settings without access to routine WBC‐evaluation.
Mefloquine was evaluated as an alternative for intermittent preventive treatment of malaria in pregnancy (IPTp) due to increasing resistance against the first-line drug sulfadoxine-pyrimethamine (SP).
Dihydroartemisinin-piperaquine (DHA-PQ) is under study for intermittent preventive treatment during pregnancy (IPTp), but it may accelerate selection for drug resistance.
Across sub-Saharan Africa, patients with HIV on antiretrovirals often get malaria and need cotreatment with artemisinin-containing therapies.
A more detailed characterization of forest activities is needed but research on this topic raises methodological challenges.
